市场调查报告书
商品编码
1466620
细胞分离/细胞分离市场:按产品类型、细胞来源、技术、应用、最终用户 - 2024-2030 年全球预测Cell Isolation/Cell Separation Market by Product (Consumables, Instruments), Cell Type (Animal Cells, Human Cells), Cell Source, Technique, Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
细胞分离/细胞分离市场规模预估2023年为113.2亿美元,2024年达129.3亿美元,2030年达到291.2亿美元,预估复合年增长率为14.44%。
细胞分离,也称为细胞分离,是生命科学和医学研究中的关键过程,它允许从异质混合物中提取和分离特定的细胞类型,以便进一步分析、研究或治疗用途。这个过程对于多种应用至关重要,包括癌症研究、干细胞研究、免疫学和组织再生。这种应用的扩展主要是由于技术进步促进了细胞治疗的更高纯度和产量、需要个人化医疗的慢性疾病的日益流行以及对细胞研究的投资增加。然而,这个过程在技术上困难、昂贵、耗时,并且存在细胞损伤和丧失的潜在风险。为了解决这些问题,目前的重点是开发结合自动化和微流体技术的更有效率、更具成本效益和良性的分离技术。随着新的治疗应用的开发、与人工智慧的整合以提高效率以及为细胞功能和疾病机制提供无与伦比的洞察力的单细胞技术的出现等新兴机会,细胞分离正在经历显着的增长。
主要市场统计 | |
---|---|
基准年[2023] | 113.2亿美元 |
预测年份 [2024] | 129.3亿美元 |
预测年份 [2030] | 291.2亿美元 |
复合年增长率(%) | 14.44% |
使用耗材确保产品结果的一致性和可靠性
耗材对于细胞分离过程至关重要,提供有效分离所需的试剂和材料。此部分进一步分为试剂、珠子和消耗品。试剂包括对细胞裂解和分离很重要的酵素和缓衝液。珠子(磁珠)提供了一种利用磁场的细胞分选方法。消耗品包括过滤器和板子等各种产品。细胞分离仪器包括用于分离和收集特定细胞类型的仪器。此领域分为离心机、流式细胞仪、磁激活细胞分选仪(MACS)和过滤系统。这些设备之一的选择取决于细胞分离的方法和所需的结果。虽然离心机通常用于满足基本的细胞分离需求,但流式细胞仪和 MACS 可以更精确地对特定细胞类型进行分选。过滤系统是批量分离的首选。
最终用户:研究机构快速普及细胞分离程序
生物技术和生物製药公司占据了细胞分离市场的主要部分。这些公司主要专注于开发疗法、疫苗和研究新药。这些公司优先考虑自动化、高通量系统,这些系统可以处理大量样品,而不会影响细胞分离的品质。医院和诊断实验室将细胞分离用于多种目的,包括诊断测定、临床试验和个人化医疗。这部分强调准确性、可靠性和速度,以帮助做出诊断和治疗决策。这些用户需要一个易于使用且强大的系统,能够快速提供结果。首选与现有工作流程无缝整合且需要最少操作员培训的设备。研究机构和机构处于细胞基础和应用研究的前沿。他们的需求集中在多功能性、敏感性以及分离稀有细胞群以用于疾病或再生医学等研究的能力。这些研究机构喜欢提供广泛功能的模组化系统,包括分离不同细胞类型和适应不同研究需求的能力。
区域洞察
在美洲,在医疗保健和强大的生物新兴企业生态系统的大量投资的推动下,生物技术和製药行业专注于利用先进的研究方法和细胞分离技术。区域公司在该地区占据主导地位,受益于完善的基础设施以及对创新和技术进步的高度重视。亚太地区细胞分离技术的采用正在迅速增加,这主要是由于政府对生物技术研究的投资增加、生物技术公司的快速发展以及对个人化医疗的日益关注。然而,该地区在生产能力和技术成熟度方面面临挑战,企业努力与西方国家的技术力相符。 EMEA(欧洲、中东和非洲)地区的情况好坏参半,因为欧洲在政府的大力支持下处于研发活动的前沿。由于医疗保健支出和意识的增加,中东和非洲逐渐成为潜在市场。欧洲、中东和非洲地区的公司对于推动创新至关重要,但它们面临来自全球巨头和亚太地区新兴企业的激烈竞争。
FPNV定位矩阵
FPNV定位矩阵对于评估细胞分离/细胞分离市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对细胞隔离/细胞分离市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1. 细胞分离/细胞分离市场的市场规模与预测是多少?
2.在细胞分离/细胞分离市场的预测期内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.细胞分离/细胞分离市场的技术趋势和法规结构是什么?
4.细胞分离/细胞分离市场主要厂商的市场占有率是多少?
5. 进入细胞分离/细胞分离市场的适当型态和策略手段是什么?
生物过程
[197 Pages Report] The Cell Isolation/Cell Separation Market size was estimated at USD 11.32 billion in 2023 and expected to reach USD 12.93 billion in 2024, at a CAGR 14.44% to reach USD 29.12 billion by 2030.
Cell isolation, also known as cell separation, is a pivotal process in life sciences and medical research, enabling the extraction and separation of specific cell types from a heterogeneous mixture for further analysis, research, or therapeutic use. This process is crucial in various applications including cancer research, stem cell research, immunology, and tissue regeneration. The expansion of its use is primarily driven by technological advancements facilitating higher purity and yield in cell therapy, increasing the prevalence of chronic diseases necessitating personalized medicine, and growing investments in cell-based research. However, the process can be technically challenging, expensive, and time-consuming, with potential risks of cell damage or loss. Addressing these issues, ongoing efforts focus on developing more efficient, cost-effective, and gentle separation techniques, incorporating automation and microfluidic technologies. Cell isolation is poised for significant growth, with opportunities emerging in the development of novel therapeutic applications, integration with artificial intelligence for improved efficiency, and the advent of single-cell technologies offering unparalleled insights into cell function and disease mechanisms.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 11.32 billion |
Estimated Year [2024] | USD 12.93 billion |
Forecast Year [2030] | USD 29.12 billion |
CAGR (%) | 14.44% |
Product: Use of consumables to ensure consistency and reliability in results
Consumables are vital to the cell isolation process, offering the necessary reagents and materials for effective separation. This segment is further divided into reagents, beads, and disposables. Reagents include enzymes and buffer solutions critical for cell lysis and separation. Beads, or magnetic beads, offer a method for cell sorting using magnetic fields. Disposables cover a range of products like filters and plates. Instruments in cell isolation encompass devices used in the separation and collection of specific cell types. This segment can be divided into centrifuges, flow cytometers, magnetic-activated cell sorters (MACS), and filtration systems. The preference between these instruments is dictated by the cell isolation method and the desired outcome. Centrifuges are commonly used for basic cell separation needs, whereas flow cytometers and MACS offer higher precision for sorting specific cell types. Filtration systems are preferred for large-volume separations.
End-User: Exponential adoption of cell isolation procedures by research institutes
Biotechnology and biopharmaceutical companies represent a major segment of the cell isolation market. These entities primarily focus on the development of therapeutics, vaccines, and research into novel drug modalities. These companies prioritize automated, high-throughput systems that can handle large volumes without compromising the quality of cell separation. Hospitals and diagnostic laboratories utilize cell isolation for various purposes, including diagnostic assays, clinical trials, and personalized medicine. This segment focuses on accuracy, reliability, and speed to aid in diagnosis and treatment decision-making. These users need easy-to-use, robust systems that can deliver rapid results. Equipment that integrates seamlessly with existing workflows and requires minimal operator training is preferred. Research laboratories and institutes are at the forefront of basic and applied research involving cell-based studies. Their needs center around versatility, sensitivity, and the ability to isolate rare cell populations for research into diseases, regenerative medicine, and more. These entities prefer modular systems that offer a wide range of capabilities, including the isolation of various cell types and the ability to adapt to different research needs.
Regional Insights
In the Americas, there is a strong emphasis on advanced research methodologies and the utilization of cell separation technologies in the biotechnology and pharmaceutical sectors, propelled by substantial investments in healthcare and a robust biotech startup ecosystem. Regional companies are dominating the region, benefitting from a well-established infrastructure and a significant focus on innovation and technological advancement. The APAC region is witnessing rapid growth in the adoption of cell isolation technologies, primarily due to increasing government investment in biotechnology research, burgeoning biotech enterprises, and a rising focus on personalized medicine. However, the region faces challenges in terms of production capabilities and technical sophistication, with companies striving to match the technological prowess seen in Western counterparts. The EMEA region presents a mixed scenario, with Europe at the forefront in terms of research and development activities driven by strong governmental support. The Middle East and Africa are slowly emerging as potential markets, owing to increasing healthcare expenditure and awareness. Companies in EMEA are pivotal in driving innovation, although they face stiff competition from global giants and emerging players in APAC.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Cell Isolation/Cell Separation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Isolation/Cell Separation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Cell Isolation/Cell Separation Market, highlighting leading vendors and their innovative profiles. These include Akadeum Life Sciences, Alfa Laval AB, Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioLegend, Inc. by PerkinElmer Inc., Capricorn Scientific, CD Bioparticles, Corning Incorporated, Cytiva by Global Life Sciences Solutions USA LLC, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., GenScript Biotech Corporation, IDEX Health & Science LLC, Invent Biotechnologies, Inc., LeanGene, Merck KGA, MiCareo Inc., Miltenyi Biotec B.V. & Co. KG, NVIGEN, Inc., pluriSelect Life Science UG & Co. KG, Promega Corporation, PromoCell GmbH, Proteintech Group, Inc., Sartorius AG, STEMCELL Technologies Inc., Takara Bio Inc., Terumo BCT, Inc., and Thermo Fisher Scientific, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Cell Isolation/Cell Separation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Isolation/Cell Separation Market?
3. What are the technology trends and regulatory frameworks in the Cell Isolation/Cell Separation Market?
4. What is the market share of the leading vendors in the Cell Isolation/Cell Separation Market?
5. Which modes and strategic moves are suitable for entering the Cell Isolation/Cell Separation Market?
bioprocessing